Acute myeloid leukemia: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(53 intermediate revisions by 12 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{DiseaseDisorder infobox |
Name = Acute myeloid leukemia |
ICD10 = {{ICD10|C|92|0|c|81}} |
ICD9 = {{ICD9|205.0}} |
ICDO = {{ICDO|9861|3}} |
Image = Auer_rods.PNG |
Caption = Bone marrow aspirate showing acute myeloid leukemia. Arrows indicate [[Auer rods]].|
OMIM = 602439 |
MedlinePlus = 000542 |
DiseasesDB = 203 |
}}
{{Acute myeloid leukemia}}
{{Acute myeloid leukemia}}


'''For patient information click [[Leukemia (patient information)|here]]'''
'''For patient information click [[Leukemia (patient information)|here]]'''


{{CMG}}; {{AE}} {{RT}}
{{CMG}}; {{AE}} {{RT}} {{CLG}} {{shyam}}; {{GRR}} {{Nat}}


==Overview==
{{SK}} AML; acute granulocytic leukaemia; acute myeloblastic leukemia; acute myelogenous leukemia; acute nonlymphocytic leukemia; M7; megakaryocytic leukemia; Acute monocytic leukemia; AMoL; AML-M5


==[[Acute myeloid leukemia overview|Overview]]==


==History==
==[[Acute myeloid leukemia historical perspective|Historical Perspective]]==


==Signs and symptoms==
==[[Acute myeloid leukemia classification|Classification]]==


==Causes==
==[[Acute myeloid leukemia pathophysiology|Pathophysiology]]==


==Epidemiology==
==[[Acute myeloid leukemia causes|Causes]]==


==Pathophysiology==
==[[Acute myeloid leukemia differential diagnosis|Differentiating Acute Myeloid Leukemia from Other Diseases]]==


==Diagnosis==
==[[Acute myeloid leukemia epidemiology and demographics|Epidemiology and Demographics]]==
The first clue to a diagnosis of AML is typically an abnormal result on a [[complete blood count]]. While an excess of abnormal white blood cells ([[leukocytosis]]) is a common finding, and leukemic blasts are sometimes seen, AML can also present with isolated decreases in [[platelet]]s, [[red blood cell]]s, or even with a ''low'' white blood cell count ([[leukopenia]]).<ref>Abeloff, Martin et al. (2004), p. 2834.</ref> While a presumptive diagnosis of AML can be made via examination of the peripheral blood smear when there are circulating leukemic blasts, a definitive diagnosis usually requires an adequate bone marrow aspiration and biopsy


A [[bone marrow examination]] is often performed to identify the type of abnormal blood cells; however, if there are many leukemic cells circulating in the peripheral blood, a bone marrow [[biopsy]] may not be necessary. Marrow or blood is examined via [[light microscopy]] as well as [[flow cytometry]] to diagnose the presence of leukemia, to differentiate AML from other types of leukemia (e.g. [[acute lymphoblastic leukemia]]), and to classify the subtype of disease (see below). A sample of marrow or blood is typically also tested for [[chromosomal translocation]]s by routine [[cytogenetics]] or [[fluorescent in situ hybridization]].
==[[Acute myeloid leukemia risk factors|Risk Factors]]==


The diagnosis and classification of AML can be challenging, and should be performed by a qualified [[hematopathologist]] or [[hematologist]]. In straightforward cases, the presence of certain morphologic features (such as [[Auer rods]]) or specific flow cytometry results can distinguish AML from other leukemias; however, in the absence of such features, diagnosis may be more difficult.<ref>Abeloff, Martin et al. (2004), p. 2835.</ref>
==[[Acute myeloid leukemia screening|Screening]]==


According to the widely used [[WHO]] criteria, the diagnosis of AML is established by demonstrating involvement of more than 20% of the blood and/or bone marrow by leukemic [[myeloblast]]s.<ref>{{cite journal | author = Harris N, Jaffe E, Diebold J, Flandrin G, Muller-Hermelink H, Vardiman J, Lister T, Bloomfield C | title = The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997 | journal = Ann Oncol | volume = 10 | issue = 12 | pages = 1419–32 | year = 1999 | pmid = 10643532}}</ref> AML must be carefully differentiated from "pre-leukemic" conditions such as [[myelodysplastic syndrome|myelodysplastic]] or [[myeloproliferative syndrome|myeloproliferative]] syndromes, which are treated differently.
==[[Acute myeloid leukemia natural history|Natural History, Complications and Prognosis]]==


Because [[acute promyelocytic leukemia]] (APL) has the highest curability and requires a unique form of treatment, it is important to quickly establish or exclude the diagnosis of this subtype of leukemia. [[Fluorescent in situ hybridization]] performed on blood or bone marrow is often used for this purpose, as it readily identifies the [[chromosomal translocation]] (t&#91;15;17&#93;) that characterizes APL.<ref>{{cite journal | author = Grimwade D, Howe K, Langabeer S, Davies L, Oliver F, Walker H, Swirsky D, Wheatley K, Goldstone A, Burnett A, Solomon E | title = Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party. | journal = Br J Haematol | volume = 94 | issue = 3 | pages = 557-73 | year = 1996 | pmid = 8790159}}</ref>
==Diagnosis==
[[Acute myeloid leukemia diagnostic study of choice|Diagnostic Study of Choice]] | [[Acute myeloid leukemia history and symptoms|History and Symptoms]] | [[Acute myeloid leukemia physical examination|Physical Examination]] | [[Acute myeloid leukemia laboratory tests|Laboratory Findings]] | [[Acute myeloid leukemia electrocardiogram|Electrocardigram]] | [[Acute myeloid leukemia chest x ray|Chest X Ray]] | [[Acute myeloid leukemia echocardiograph and ultrasound|Echocardiograph and Ultrasound]] | [[Acute myeloid leukemia CT|CT]] | [[Acute myeloid leukemia mri|MRI]] | [[Acute myeloid leukemia other imaging findings|Other Imaging Findings]] | [[Acute myeloid leukemia other diagnostic studies|Other Diagnostic Studies]]


===Pathology===
==Treatment==
 
[[Acute myeloid leukemia medical therapy|Medical Therapy]] | [[Acute myeloid leukemia surgery|Surgery]] | [[Acute myeloid leukemia primary prevention|Primary Prevention]] | [[Acute myeloid leukemia secondary prevention|Secondary Prevention]] | [[Acute myeloid leukemia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Acute myeloid leukemia future or investigational therapies|Future or Investigational Therapies]]
<div align="left">
<gallery heights="175" widths="175">
Image:AML.jpg|AML - Auer Rods, DIC<ref>http://picasaweb.google.com/mcmumbi/USMLEIIImages</ref>
Image:AML (with Auer Rods).jpg|AML (with Auer Rods)<ref>http://picasaweb.google.com/mcmumbi/USMLEIIImages</ref>
</gallery>
</div>
 
 
(Images shown below are courtesy of Melih Aktan MD., Istanbul Medical Faculty - Turkey, and Kyoto University - Japan)


<div align="left">
==Case Studies==
<gallery heights="175" widths="175">
[[Acute myeloid leukemia case study one|Case #1]]
Image:AML-M0 0001.jpg|AML-M0
Image:AML-M1 0002.jpg|AML-M1
</gallery>
</div>


 
==Related Chapters==
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M1 peroxidase 0001.jpg|AML-M1 peroxidase
Image:AML-M1 0005.jpg|AML-M1
</gallery>
</div>
 
 
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M1 0004.jpg|AML-M1
Image:AML-M1 0003.jpg|AML-M1
</gallery>
</div>
 
 
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M2 0002.jpg|AML-M2
Image:AML-M2 0001.jpg|AML-M2
</gallery>
</div>
 
 
</div>
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M2 0004.jpg|AML-M2
Image:AML-M2 0003.jpg|AML-M2
</gallery>
</div>
 
 
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M3 0006.jpg|AML-M3 
Image:AML-M3 0004.jpg|AML-M3
</gallery>
</div>
 
 
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M3 0002.jpg|AML-M3
Image:AML-M3 0001.jpg|AML-M3
</gallery>
 
 
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M3 Auer bodies 0005.jpg|AML-M3 Auer bodies
Image:AML-M3 Auer bodies 0003.jpg|AML-M3 Auer bodies
</gallery>
</div>
 
 
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M3 variation 0007.jpg|AML-M3 variation
Image:AML-M4 0001.jpg|AML-M4
</gallery>
</div>
 
 
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M5a 0003.jpg|AML-M5a
Image:AML-M5a 0001.jpg|AML-M5a
</gallery>
</div>
 
 
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M5a alpha naphtyle acetat 0002.jpg|AML-M5a (alpha naphtyle acetat)
Image:AML-M5b 0001.jpg|AML-M5b
</gallery>
</div>
 
 
<div align="left">
<gallery heights="175" widths="175">
Image:AML-M5b 0002.jpg|AML-M5b
Image:AML-M7 0001.jpg|AML-M7
Image:AML-M7 CD41 0001.jpg|AML-M7
</gallery>
</div>
 
==Classification==
 
==Prognosis==
 
==Treatment==
 
==See also==
* [[Chloroma]]
* [[Chloroma]]
* [[Chronic myelogenous leukemia]]
* [[Chronic myelogenous leukemia]]
* [[Acute lymphoblastic leukemia]]
* [[Acute lymphoblastic leukemia]]
==Further reading==
* {{cite book |author = Martin Abeloff |coauthors= James Armitage, John Niederhuber, Michael Kastan, W. Gillies McKenna |title= Clinical Oncology |year= 2004 |publisher= Elsevier Churchill Livingstone |location= St. Louis, Mo. |edition = 3rd. edition |id= ISBN 0-443-06629-9}}
* {{cite book |author = Ronald Hoffman |coauthors= Edward Benz, Jr., Sanford Shattil, Bruce Furie, Harvey Cohen, Leslie Silberstein, Philip McGlave |title= Hematology: Basic Principles and Practice |year= 2005 |publisher= Elsevier Churchill Livingstone |location= St. Louis, Mo. |edition = 4th. edition |id= ISBN 0-443-06629-9}}
==References==
{{reflist|2}}


==External links==
==External links==


* [http://www.kanbilim.com/dahiliyeatlasi.htm Atlas of Hematology]
* [http://www.cancer.org/docroot/CRI/CRI_2_1x.asp?rnav=criov&dt=82 American Cancer Society page on Acute Myeloid Leukemia]
* [http://leukemia.acor.org/ Association of Cancer Online Resource (ACOR) Leukemia Links]
* [http://www.leukemia-lymphoma.org/all_page?item_id=8459 Leukemia & Lymphoma Society page on Acute Myeloid Leukemia]
* [http://www.cchs.net/health/health-info/docs/1400/1403.asp?index=6211 Childhood Acute Myeloid Leukemia]
* [http://www.marrow.org National Marrow Donor Program]
* [http://www.bmtinfonet.org/ Blood & Marrow Transplant Information Network]
* [http://www.cancer.gov/cancer_information/doc.aspx?viewid=4d3f920e-87d6-4b6a-a2fe-74c6efa53398&version=1 National Cancer Institute (NCI) PDQ statement on AML for health professionals]
* [http://www.cancer.gov/cancer_information/doc.aspx?viewid=4d3f920e-87d6-4b6a-a2fe-74c6efa53398&version=1 National Cancer Institute (NCI) PDQ statement on AML for health professionals]


Line 181: Line 49:
{{Hematological malignancy histology}}
{{Hematological malignancy histology}}


[[ar:ابيضاض الدم النقوي الحاد]]
 
[[de:Akute myeloische Leukämie]]
[[es:Leucemia mieloide aguda]]
[[he:לוקמיה מיאלואידית חריפה]]
[[ja:急性骨髄性白血病]]
[[pl:Ostra białaczka szpikowa]]
[[pt:Leucemia mielóide aguda]]
[[sr:Акутна мијелоцитна леукемија]]
[[sv:Akut myeloisk leukemi]]
[[zh:急性骨髓性白血病]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}


[[Category:Disease]]
[[Category:Disease]]  
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Overview complete]]
[[Category:Leukemia]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Hematology]]
[[Category:Immunology]]

Latest revision as of 17:44, 4 April 2019

Acute myeloid leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute myeloid leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardigram

Chest X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute myeloid leukemia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute myeloid leukemia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute myeloid leukemia

CDC on Acute myeloid leukemia

Acute myeloid leukemia in the news

Blogs on Acute myeloid leukemia

Directions to Hospitals Treating Acute myeloid leukemia

Risk calculators and risk factors for Acute myeloid leukemia

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2] Carlos A Lopez, M.D. [3] Shyam Patel [4]; Grammar Reviewer: Natalie Harpenau, B.S.[5]

Synonyms and keywords: AML; acute granulocytic leukaemia; acute myeloblastic leukemia; acute myelogenous leukemia; acute nonlymphocytic leukemia; M7; megakaryocytic leukemia; Acute monocytic leukemia; AMoL; AML-M5

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute Myeloid Leukemia from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardigram | Chest X Ray | Echocardiograph and Ultrasound | CT | MRI | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters

External links

Template:Blood


Template:WikiDoc Sources